Li et al. (2021), based on a panel of migration assays on ovarian cancer cells (SKOV3 and CaOV3), showed that EZR downregulation limited the migratory potential of ovarian cancer cells, while upregulation enhanced it [14]. The gene discussed is EZR; the disease is ovarian carcinoma.